Black children less likely to get proton radiotherapy
September 2, 2020 -- Black children enrolled in national clinical trials are three times less likely to receive proton radiotherapy than white children, according to research published August 6 in JAMA Oncology.
September 2, 2020 -- Black children enrolled in national clinical trials are three times less likely to receive proton radiotherapy than white children, according to research published August 6 in JAMA Oncology.
Jubilant to distribute Eckert & Ziegler's GalliaPharm
September 2, 2020 -- Jubilant Radiopharma signed an exclusive deal to distribute isotope technology firm Eckert & Ziegler's GalliaPharm germanium-68/gallium-68 generator in Canada.
September 2, 2020 -- Jubilant Radiopharma signed an exclusive deal to distribute isotope technology firm Eckert & Ziegler's GalliaPharm germanium-68/gallium-68 generator in Canada.
Mevion joins forces with Proton International
September 1, 2020 -- Mevion Medical Systems is teaming up with Proton International on a contract to provide Mevion's compact proton therapy technology to two new proton therapy centers in the southern U.S.
September 1, 2020 -- Mevion Medical Systems is teaming up with Proton International on a contract to provide Mevion's compact proton therapy technology to two new proton therapy centers in the southern U.S.
No need to defer cancer treatment for fear of COVID-19
August 27, 2020 -- Patients shouldn't postpone their cancer treatment for fear of SARS-CoV-2 infection by visiting healthcare facilities, according to a research letter published online August 27 in JAMA Oncology. Researchers found little risk of infection if appropriate disinfection protocols are followed.
Discuss
August 27, 2020 -- Patients shouldn't postpone their cancer treatment for fear of SARS-CoV-2 infection by visiting healthcare facilities, according to a research letter published online August 27 in JAMA Oncology. Researchers found little risk of infection if appropriate disinfection protocols are followed.
Discuss Single radiotherapy dose effective for breast cancer
August 27, 2020 -- A single dose of targeted radiotherapy during a lumpectomy procedure proved effective in a long-term clinical trial of thousands of women with early-stage breast cancer. The international team behind the large, randomized trial published their results on August 19 in the BMJ.
Discuss
August 27, 2020 -- A single dose of targeted radiotherapy during a lumpectomy procedure proved effective in a long-term clinical trial of thousands of women with early-stage breast cancer. The international team behind the large, randomized trial published their results on August 19 in the BMJ.
Discuss NCI, Cancer Research U.K. fund project to spur cancer research
August 27, 2020 -- The U.S. National Cancer Institute (NCI) has partnered with Cancer Research U.K. to fund Cancer Grand Challenges, an international initiative to support new ideas for cancer research.
August 27, 2020 -- The U.S. National Cancer Institute (NCI) has partnered with Cancer Research U.K. to fund Cancer Grand Challenges, an international initiative to support new ideas for cancer research.
IBA reports reduced half-year revenues
August 27, 2020 -- Proton therapy developer Ion Beam Applications (IBA) reported reduced revenues for the first half of 2020, which it attributed to challenges presented by the COVID-19 pandemic.
August 27, 2020 -- Proton therapy developer Ion Beam Applications (IBA) reported reduced revenues for the first half of 2020, which it attributed to challenges presented by the COVID-19 pandemic.
Accuray's Q4, fiscal year revenues decline
August 14, 2020 -- Radiation oncology firm Accuray has released financial results for its fourth quarter and fiscal year that show a drop in revenue from last year.
August 14, 2020 -- Radiation oncology firm Accuray has released financial results for its fourth quarter and fiscal year that show a drop in revenue from last year.
Follow-up SPECT/CT scan tracks radionuclide dose
August 13, 2020 -- Australian researchers have developed a technique that uses a follow-up SPECT/CT scan after radionuclide therapy to personalize the radiation dose delivered, according to a study published in the July issue of the Journal of Nuclear Medicine.
Discuss
August 13, 2020 -- Australian researchers have developed a technique that uses a follow-up SPECT/CT scan after radionuclide therapy to personalize the radiation dose delivered, according to a study published in the July issue of the Journal of Nuclear Medicine.
Discuss Report: I-123 shortages force Australia to charter flights
August 13, 2020 -- The COVID-19 pandemic has forced Australia to spend hundreds of thousands of dollars on charter flights to import iodine-123 (I-123) radioisotopes for use in cancer treatments, according to an August 10 article in the Guardian.
August 13, 2020 -- The COVID-19 pandemic has forced Australia to spend hundreds of thousands of dollars on charter flights to import iodine-123 (I-123) radioisotopes for use in cancer treatments, according to an August 10 article in the Guardian.
Special Feature
IMV: Imaging boosts precision in radiation therapy
Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more
VENDOR CONNECT